Bloodroot kills cancer
The effect of bloodroot capsules and its antiproliferative and apoptosis nature was investigated and the following found to be true:
Bloodroot stops cancerous cells rapid growth.
Bloodroot stops cancerous cells from abnormally increasing in number.
Bloodroot stops the promotion of human epidermoid carcinoma cells, i.e., squamous cell (squamous cell is an invasive malignant tumor derived from epithelial tissue that tends to metastasize to other areas of the body).
Bloodroot promotes the natural self-destruction (apoptosis) of cancer cells.
Bloodroot will not promote apoptosis at any strength or concentration to health, tissue.
Bloodroot will promote necrosis (cell death ) in healthy epidermal keratinocytes (keratinocytes are the predominant cell type in the epidermis and dermis i.e. skin tissue) in concentrations above -10 µM (10-6 per unit).
How Does An Enzyme Know The Cell Is Carcinoma In Nature, Defective or Dead?
This question has puzzled many. There are two basic theories. The first and oldest is called vitalism (The doctrine that all the functions of a living organism are due to an unknown vital principle distinct from all chemical and physical forces). The newest is called physicist or physiciststism (A believe in the theory that the fundamental phenomena of life are to be explained upon purely chemical and physical principles; opposed to vitalist.). Both are a doctrine or theory; an "ism" being a visionary theory.
With that stated, here are the facts:
Living cells are able to communicate one to another.
Living cell are able to request nutrients from adjacent cells i.e transcellular-migration. (This is not limited to only nutrients entering the cells and waste products leaving the cell i.e. lactate, cells have the ability to allow transcellular-migration of extremely large enzymes and nutrients.)
Living cells give off signals allowing the body to identify the health and state of the cell. An example of health and state is a cell undergoing natural occurring apoptosis (the body needs to be aware of narcosis of cell-(s) and be ready to replace the cell, unitize the energy from the narcotic cell.) and carcinoma cells utilizing greater amounts of glucose. While the cell is in the state of aerobic or anaerobic rest the consumption of glucose is abnormally high.
The body can identify carcinoma cells.
These four facts are very important to the understanding of enzyme therapy. We must understand that an enzyme is a natural catalyst but displays the attributes of living matter. (Example of a simple chemical catalyst is sodium hydroxide (caustic soda) this is use to make every thing from hand soap to writing paper. Sodium hydroxide freely exchanges ions to accomplish the chemical reactions.).
Enzymes are different from simple chemicals, they belong to special branch of chemistry called biochemistry. This is because the molecules found in living organisms not only conform to all the familiar physical and chemical principles governing the behavior of all molecules but, in addition, interact with each other in accordance with another set of principles that we shall refer to as the molecular logic of the living state.
These principles do not necessarily involve any new or as yet undiscovered physical laws of forces. Rather, they should be regarded as a set of ground rules that govern the nature, function self replication and interactions of the specific types of molecules fround in the living organisms. Not all the principles comprised by the molecular logic of the living state have yet been completely identified; indeed, some are only dimly perceived. In fact, it is perhaps more appropriate to speak of these principles as axioms, since some of them are intuitive and not yet definitively provable.
The Lining of the Intestines and its Function
It is known that the lining of the intestine is an active tissue that breaks down nutrients and selects what it will or will not allow to be absorbed into the blood stream. This active organ breaks down nutrients, selects those to be absorbed by the bloodstream, and controls the speed with which the action takes place.
Absorption of Enzymes
Research continues to show enzyme absorption methods in new and dynamic ways, and we now know that the intestinal lining absorbs enzymes. Today we know that enzyme absorption is possible... and in fact this process occurs daily.
Enzyme absorption occurs through two main methods:
Pinocytosis (Root word pinocyte, origin: Greek, Pineo, to drink, + kytos, cell, that is to say in English, "to drink".) Technically speaking, uptake of fluid filled vesicles into cells (endocytosis). The action of pinocytosis is a distinct processes, being energy independent and involving the formation of receptor ligand clusters, this is described technically by saying: Any molecule, including enzymes, that binds to substances (i.e. water) which in turn allows the usage of water soluble molecules such as the TumorX Enzyme to bind to a receptor (i.e. amylase)-connected-to-water. When this process takes place the TumorX enzymes are able to migrate through the wall of the gut and directly into the bloodstream. A simpler comparison is the elevator. A person steps into an elevator on the first floor and the door closes behind them. Upward the elevator travels, the door opens and the person steps out onto the second floor. Similarly, the intestinal lining encloses and engulfs enzymes that travel to and from the second floor (bloodstream) where the door opens, releasing the passenger (s) (amylase enzyme).
Once the enzymes are in the bloodstream the enzymes can travel to the lymphatic system. This is achieved by the enzymes hitching a ride via the lymphocytes, that is to say, the white blood cells which help fight disease and infection. This process helps the enzymes travel through the vascular system easily and effectively.
Peristalsis (Root word Stalsis, origin: Greek; that is to say in English, "contraction".) Transcellular absorption or migration is the process in which large enzymes and nutrients are pushed in a wormlike movement by the digestive tract through the small intestine. This provides both longitudinal and circular motion using the contraction and release of the cells in a juxtapositional relationship; the enzymes travel along the epithelium component of the cell. In essence, the cells’ surrounding tissue consists of a wave like motion caused by the contraction. The enzymes pass through the tube-like passage, made exclusively for the passing enzyme, for variable distances throughout the body until the enzymes find carcinoma, damaged cells (pre-cancerous cells), or debris in the body.
If the enzymes are not utilized, the enzymes are then forced into the bloodstream to travel around the vascular system until a location or opportunity arises where the catalyst action of the enzymes can be positively utilized.
Cancer and Calcium
Calcium contributes to the progression of epithelial cells through all phases of the proliferative cycle and into stages of cell differentiation. Intracellular concentrations of calcium that are required for cell renewal, however, are lower than those required for epithelial-cell differentiation.
In rodents studies, a nutritional stress diet (low calcium), designed to represent human Western dietary intake of calcium, produced and allowed cancer to multiply faster than when larger doses of calcium were added to the diet.
In human subjects with family history of colon cancer, colon cancer cells were reduced after oral dietary supplementation with calcium. In epidemiological studies, several investigators reported inverse correlations between levels of dietary calcium intake and the incidence of colon cancer. Extrapolation of the data have suggested a protective effect of total calcium intakes above 1500 to 1800 mg of elemental calcium per day. This evidence was published by HL Newmark and M Lipkin Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
When Calcium was blocked Cancer Rates Increased
Calcium channel blockers block calcium signal-mediated apoptosis. It is hypothesized that the use of these drugs may be associated with the development of cancer. This study investigated the association between daily use of calcium channel blockers and prostate cancer in a community-based cohort of men who participated in a longitudinal study of lower urinary tract symptoms. Study subjects were men ages 40 to 79 years by January 1, 1990, and were randomly selected from Olmsted County in Minnesota. At baseline, participants underwent an interview to determine all medications taken on a daily basis, including calcium channel blockers, and were also elicited about family history of prostate cancer. These findings suggest an association between prostate cancer and the daily use of calcium channel blockers (drugs used to stop the body’s uptake of calcium) that varies by family history of prostate cancer.
This evidence was published by: Jose D. Debes1, Rosebud O. Roberts3, Debra J. Jacobson4, Cynthia J. Girman3,5, Michael M. Lieber1, Donald J. Tindall1,2 and Steven J. Jacobsen3 1 Department of Urology, 2 Department of Biochemistry/Molecular Biology, and 3 Department of Health Sciences Research, Division of Epidemiology, and 4 Division of Biostatistics, Mayo Clinic, Rochester, Minnesota, and 5 Merck Research Laboratories, Blue Bell, Pennsylvania